First Trust Nasdaq Pharmaceuticals ETF (FTXH:NASDAQ) closed at $42.68 on October 23, 2026, down 1.17% on the day. The stock trades 1.9% below its 52-week high of $43.52 and 45.1% above its 52-week low of $29.40. First Trust Nasdaq Pharmaceuticals ETF is part of the Miscellaneous sector.
In 252 trading sessions since October 23, 2025, FTXH closed higher on 125 days (50%). Its best day was August 19, 2026 (+4.79%) and its worst was August 20, 2026 (-2.21%). It never moved 10% or more in a single session.
The investment seeks investment results that correspond generally to the price and yield (before the fund's fees and expenses) of the Nasdaq US Smart Pharmaceuticals Index. The fund will normally invest at least 90% of its net assets (including investment borrowings) in common stocks that comprise the index. The index is designed to select pharmaceuticals stocks from the base index based on a ranking methodology of three price factors which aims to select companies that exhibit: strong growth through high average 3-, 6-, 9- and 12-month price return; value; and low expected volatility based on historical stock price fluctuation. It is non-diversified.
Find more stocks like FTXH with the Spikes, Gaps, Breakouts and Performance Tracker scanners.
Based on end-of-day data. For information only, not investment advice.